Literature DB >> 8977328

Protective major histocompatibility complex genes and the role of interleukin-4 in collagen-induced arthritis.

M Hesse1, S Bayrak, A Mitchison.   

Abstract

To investigate the role of interleukin (IL)-4 during the triggering of collagen-induced arthritis, we examined the effects of the I-A(b) and I-E protective/suppressive genes and passively administered anti-IL-4 monoclonal antibody. In contrast to the action of I-E expression on its own, which has mainly a suppressive effect post-triggering, the combination of I-A(b) and I-E had a marked protective effect. Assuming, on the basis of previous experience with the I-A(b) allele, that it might act through suppressing early IL-4 production, we treated mice with the 11B11 IL-4-neutralizing antibody around the time of initial immunization with collagen. Treatment over a period extending to 6 days post-immunization exacerbated the arthritis, but when curtailed to 2 days post-immunization (and tested in pristane-primed animals), the disease was reduced. We conclude that IL-4 plays an essential role in triggering the disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8977328     DOI: 10.1002/eji.1830261259

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

Review 1.  Natural and induced regulation of Th1/Th2 balance.

Authors:  N A Mitchison; D Schuhbauer; B Müller
Journal:  Springer Semin Immunopathol       Date:  1999

2.  B cells in autoimmunity.

Authors:  N A Mitchison; L R Wedderburn
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

3.  Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype.

Authors:  M Afanasyeva; Y Wang; Z Kaya; S Park; M J Zilliox; B H Schofield; S L Hill; N R Rose
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 4.  Cytokine therapy in rheumatoid arthritis.

Authors:  J Hermann; M Walmsley; F M Brennan
Journal:  Springer Semin Immunopathol       Date:  1998

Review 5.  Gene therapy for rheumatoid arthritis. Theoretical considerations.

Authors:  Y Chernajovsky; A Annenkov; C Herman; K Triantaphyllopoulos; D Gould; H Dreja; S P Moyes; J L Croxford; R A Mageed; O L Podhajcer; D Baker
Journal:  Drugs Aging       Date:  1998-01       Impact factor: 3.923

Review 6.  The importance of the back-signal from T cells into antigen-presenting cells in determining susceptibility to parasites.

Authors:  B Müller; A Mitchison
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-09-29       Impact factor: 6.237

Review 7.  Modulating the Th1/Th2 balance in inflammatory arthritis.

Authors:  B Müller; U Gimsa; N A Mitchison; A Radbruch; J Sieper; Z Yin
Journal:  Springer Semin Immunopathol       Date:  1998

8.  Patterned variation in murine MHC promoters.

Authors:  N Avrion Mitchison; Jurgen Roes
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-19       Impact factor: 11.205

9.  Differential expression of major histocompatibility complex class II genes on murine macrophages associated with T cell cytokine profile and protective/suppressive effects.

Authors:  M Baumgart; V Moos; D Schuhbauer; B Müller
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

10.  Bystander suppression of murine collagen-induced arthritis by long-term nasal administration of a self type II collagen peptide.

Authors:  S Bayrak; N A Mitchison
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.